Cancer stem cells and drug resistance: the potential of nanomedicine
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer stem cells and drug resistance: the potential of nanomedicine
Authors
Keywords
-
Journal
Nanomedicine
Volume 7, Issue 4, Pages 597-615
Publisher
Future Medicine Ltd
Online
2012-04-04
DOI
10.2217/nnm.12.22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells
- (2016) Jia Guo et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells
- (2012) Yan-Hong Deng et al. Chinese Journal of Cancer
- Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia
- (2011) Brian M. Barth et al. ACS Nano
- Novel Anticancer Polymeric Conjugates of Activated Nucleoside Analogues
- (2011) Thulani H. Senanayake et al. BIOCONJUGATE CHEMISTRY
- The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery
- (2011) Hong-Juan Yao et al. BIOMATERIALS
- Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells
- (2011) Liang Zhang et al. BIOMATERIALS
- A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors
- (2011) Kah Jing Lim et al. CANCER BIOLOGY & THERAPY
- Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche
- (2011) C. Grange et al. CANCER RESEARCH
- Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133
- (2011) E. Bourseau-Guilmain et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology
- (2011) Lara Milane et al. JOURNAL OF CONTROLLED RELEASE
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer
- (2011) Veronika Mamaeva et al. MOLECULAR THERAPY
- P-Glycoprotein Antibody Functionalized Carbon Nanotube Overcomes the Multidrug Resistance of Human Leukemia Cells
- (2010) Ruibin Li et al. ACS Nano
- Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells
- (2010) Ying Teng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles
- (2010) Tae-Hee Kim et al. BIOMATERIALS
- Core–shell hybrid nanogels for integration of optical temperature-sensing, targeted tumor cell imaging, and combined chemo-photothermal treatment
- (2010) Weitai Wu et al. BIOMATERIALS
- The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes
- (2010) Kamal K. Upadhyay et al. BIOMATERIALS
- The modification of siRNA with 3′ cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes
- (2010) Vishakha V. Ambardekar et al. BIOMATERIALS
- Water-dispersible multifunctional hybrid nanogels for combined curcumin and photothermal therapy
- (2010) Weitai Wu et al. BIOMATERIALS
- Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells
- (2010) Feng Jin et al. BRAIN RESEARCH
- Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics
- (2010) Vanessa Rausch et al. CANCER RESEARCH
- BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization
- (2010) Junichi Shigeta et al. CANCER SCIENCE
- Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles
- (2010) E. S. Glazer et al. CLINICAL CANCER RESEARCH
- Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
- (2010) T Kato et al. GENE THERAPY
- Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs
- (2010) Carlos M. Galmarini et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer
- (2010) Yunching Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Uptake of synthetic Low Density Lipoprotein by leukemic stem cells — a potential stem cell targeted drug delivery strategy
- (2010) Peixun Zhou et al. JOURNAL OF CONTROLLED RELEASE
- All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells
- (2010) Ruo-Jing Li et al. JOURNAL OF CONTROLLED RELEASE
- Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer
- (2010) D. L. Schwartz et al. MOLECULAR CANCER THERAPEUTICS
- Pulsed Ultrasound Enhances Nanoparticle Penetration into Breast Cancer Spheroids
- (2010) Stephanie J. Grainger et al. MOLECULAR PHARMACEUTICS
- Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells
- (2010) Lara Milane et al. MOLECULAR PHARMACEUTICS
- Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms
- (2010) Tingjun Lei et al. Nanomedicine-Nanotechnology Biology and Medicine
- Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody
- (2010) Chung-Hao Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance
- (2010) Honoki ONCOLOGY REPORTS
- Up-regulated expression of stathmin may be associated with hepatocarcinogenesis
- (2010) Liu ONCOLOGY REPORTS
- Multifunctional Peptide-PEG Intercalating Conjugates: Programmatic of Gene Delivery to the Blood-Brain Barrier
- (2010) Hongwei Zhang et al. PHARMACEUTICAL RESEARCH
- Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate
- (2010) Koos E. Hovinga et al. STEM CELLS
- Identification and targeting of cancer stem cells
- (2009) Tobias Schatton et al. BIOESSAYS
- Self-assembled hyaluronic acid nanoparticles for active tumor targeting
- (2009) Ki Young Choi et al. BIOMATERIALS
- The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
- (2009) Yogesh B. Patil et al. BIOMATERIALS
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells
- (2009) Masayoshi Kobune et al. CANCER SCIENCE
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
- (2009) B. Rochat CURRENT CANCER DRUG TARGETS
- Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
- (2009) T. Wilson et al. CURRENT CANCER DRUG TARGETS
- CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
- (2009) Sung Pil Hong et al. INTERNATIONAL JOURNAL OF CANCER
- HIF-1α modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines
- (2009) Yun Jung Choi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel
- (2009) Changxing Liu et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
- (2009) Yogesh Patil et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance
- (2009) Ayman Khdair et al. JOURNAL OF CONTROLLED RELEASE
- Looking ahead in cancer stem cell research
- (2009) John E Dick NATURE BIOTECHNOLOGY
- Expression of Multidrug Resistance Genes in Normal and Cancer Stem Cells
- (2008) A. Shervington et al. CANCER INVESTIGATION
- Is Tumor Growth Sustained by Rare Cancer Stem Cells or Dominant Clones?
- (2008) J. M. Adams et al. CANCER RESEARCH
- Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling
- (2008) Chen Hu et al. CARCINOGENESIS
- Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 -deficient mouse embryonic fibroblasts
- (2008) R. Wirthner et al. CARCINOGENESIS
- Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer
- (2008) A. Verma et al. CLINICAL CANCER RESEARCH
- A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity
- (2008) A. Banzato et al. CLINICAL CANCER RESEARCH
- Nucleoside analogs: molecular mechanisms signaling cell death
- (2008) B Ewald et al. ONCOGENE
- Aldehyde Dehydrogenase as a Marker for Stem Cells
- (2008) Jan Moreb Current Stem Cell Research & Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started